[CHRS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -65.25%
YoY- -75.25%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 82,503 87,643 83,034 110,419 113,551 135,674 116,180 -20.38%
PBT -38,528 -29,900 -172,947 10,760 28,116 60,325 36,505 -
Tax 5,801 5,758 5,709 1,052 183 1,294 933 237.75%
NP -38,528 -29,900 -172,947 9,708 27,933 59,031 35,572 -
Tax Rate - - - -9.78% -0.65% -2.15% -2.56% -
Total Cost 121,031 117,543 255,981 100,711 85,618 76,643 80,608 31.09%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -46.70 -34.12 -208.28 8.79 24.60 43.51 30.62 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.49 -0.40 -2.37 0.13 0.39 0.83 0.50 -
EPS Diluted -0.49 -0.40 -2.37 0.12 0.33 0.70 0.48 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.